- Report
- August 2023
- 56 Pages
Global
From €3490EUR$3,950USD£3,021GBP
- Drug Pipelines
- July 2023
- 30 Pages
United States
From €2430EUR$2,750USD£2,103GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2430EUR$2,750USD£2,103GBP
- Report
- July 2023
- 117 Pages
Global
From €6627EUR$7,500USD£5,736GBP
- Report
- July 2023
- 243 Pages
Global
From €6627EUR$7,500USD£5,736GBP
- Report
- July 2023
- 58 Pages
Global
From €3490EUR$3,950USD£3,021GBP
- Report
- June 2023
- 115 Pages
United States
From €3313EUR$3,750USD£2,868GBP
- Report
- April 2023
- 161 Pages
Global
From €6627EUR$7,500USD£5,736GBP
- Report
- April 2023
- 145 Pages
Global
From €6627EUR$7,500USD£5,736GBP
- Report
- August 2022
- 239 Pages
Global
From €6627EUR$7,500USD£5,736GBP
- Report
- August 2022
- 62 Pages
Global
From €3490EUR$3,950USD£3,021GBP
- Report
- August 2022
- 119 Pages
Global
From €3490EUR$3,950USD£3,021GBP
- Report
- August 2022
- 100 Pages
Global
From €3490EUR$3,950USD£3,021GBP
- Report
- June 2022
- 67 Pages
Global
From €3490EUR$3,950USD£3,021GBP
- Report
- January 2022
- 200 Pages
Global
From €6627EUR$7,500USD£5,736GBP
- Report
- January 2022
- 200 Pages
Global
From €6627EUR$7,500USD£5,736GBP
- Report
- January 2022
- 200 Pages
Global
From €6627EUR$7,500USD£5,736GBP
- Report
- January 2022
- 200 Pages
Global
From €6627EUR$7,500USD£5,736GBP
- Report
- January 2022
- 200 Pages
Global
From €6627EUR$7,500USD£5,736GBP
- Report
- January 2022
- 200 Pages
Global
From €6627EUR$7,500USD£5,736GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more